[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350372-105":59,"doc-detail-350372-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","successful-management-of-metachronous-dual-primary-esophageal-carcinomas-first-report-of-consecutive-adenoid-cystic-carcinoma-and-squamous-cell-carcinoma-with-exceptional-treatment-outcome-a-case-report","Successful management of metachronous dual primary esophageal carcinomas: first report of consecutive adenoid cystic carcinoma and squamous cell carcinoma with exceptional treatment outcome - a case report","","Esophageal adenoid cystic carcinoma (ACC) is exceptionally rare, and the emergence of second primary malignancies (SPMs) after curative ACC therapy remains insufficiently characterized. This case report describes the first documented metachronous development of esophageal squamous cell carcinoma (SCC) outside the prior radiation field following definitive treatment of primary esophageal ACC. The patient achieved complete remission after curative-intent chemoradiotherapy and stayed disease-free at the latest follow-up in March 2026. The report highlights the need for comprehensive endoscopic surveillance of the entire esophagus to enable early detection and timely curative management.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/successful-management-of-metachronous-dual-primary-esophageal-carcinomas-first-report-of-consecutive-adenoid-cystic-carcinoma-and-squamous-cell-carcinoma-with-exceptional-treatment-outcome-a-case-report/350372/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/successful-management-of-metachronous-dual-primary-esophageal-carcinomas-first-report-of-consecutive-adenoid-cystic-carcinoma-and-squamous-cell-carcinoma-with-exceptional-treatment-outcome-a-case-report/350372.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What rare clinical scenario does this case report describe?","Question",{"text":112,"@type":113},"It describes metachronous dual primary esophageal cancers: adenoid cystic carcinoma followed by squamous cell carcinoma arising outside the previously irradiated field.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the initial esophageal adenoid cystic carcinoma treated?",{"text":117,"@type":113},"The patient underwent surgical resection and then received adjuvant radiotherapy to the tumor bed, which was well tolerated.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the outcome after the second primary SCC was detected and treated?",{"text":121,"@type":113},"Definitive chemoradiotherapy led to complete remission, and the patient remained disease-free at the latest follow-up in March 2026.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350372,1790807636,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Case Report  \nPUBLISHED 22 May 2026  \nDOI 10.3389/fonc.2026.1760081  \nOPEN ACCESS  \nEDITED BY  \nFrancesco Cuccia,  \nARNAS Ospedali Civico Di Cristina Benfratelli, Italy  \nREVIEWED BY  \nJingfang Mao,  \nFudan University, China Lorenzo Giorgi,  \nHumanitas Research Hospital, Italy  \n*CORRESPONDENCE  \nGang Feng  \n[fenggangmych@sina.com](fenggangmych@sina.com)[ ](fenggangmych@sina.com)Jie Li  \n [lijie.7181@163.com](lijie.7181@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 03 December 2025  \nREVISED 06 May 2026  \nACCEPTED 12 May 2026  \nPUBLISHED 22 May 2026  \nCITATION  \nBai Y, Geng L, Yang X, Shi Q, Li J and Feng G (2026) Successful management of metachronous dual primary esophageal carcinomas: ﬁrst report of consecutive adenoid cystic carcinoma and squamous cell carcinoma with exceptional treatment outcome—a case report.  \nFront. Oncol. 16:1760081 .  \ndoi: 10.3389/fonc.2026.1760081  \nCOPYRIGHT  \n© 2026 Bai, Geng, Yang, Shi, Li and Feng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nSuccessful management of metachronous dual primary esophageal carcinomas: ﬁrst report of consecutive adenoid cystic carcinoma and squamous cell carcinoma with exceptional treatment outcome—a case report  \nYuxi Bai 1†, Lidan Geng 1†, Xiyue Yang2,3, Qiuling Shi 3, Jie Li 1*† and Gang Feng 1*†  \n1 Department of Oncology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology, Mianyang, Sichuan, China, 2 Day-Treatment Center, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology, Mianyang, Sichuan, China, 3State Key Laboratory of Ultrasound in Medicine and Engineering, School of Public Health and Management, Chongqing Medical University, Chongqing, China  \nBackground: Esophageal adenoid cystic carcinoma (ACC) is an exceptionally rare malignancy, and its association with second primary malignancies (SPMs) remains poorly characterized. This report presents the ﬁrst documented case of metachronous esophageal squamous cell carcinoma (SCC) developing outside the radiation ﬁeld following curative treatment of esophageal ACC.  \nCase presentation: A 58-year-old male with a substantial smoking history presented with dysphagia in 2022 . Diagnostic evaluation conﬁrmed primary esophageal ACC (pT2N0M0, Stage IIA), exhibiting perineural invasion and a high proliferative index (Ki-67 80%) . The patient underwent surgical resection followed by adjuvant radiotherapy (50 Gy/25 fractions) to the tumor bed. Postoperative radiotherapy was well tolerated, with only Grade 1 esophagitis and fatigue observed. Sixteen months later, during routine surveillance, a new cervical esophageal lesion was detected 5 cm proximal to the previous anastomotic site, well beyond the prior radiation ﬁeld. Histopathological examination identiﬁed poorly differentiated SCC with distinct immunohistochemical characteristics (P40 diffuse+, Ki-67 30%) . Complete remission was achieved following deﬁnitivechemoradiotherapy (60 Gy/28 fractions to PGTV, 54 Gy/28 fractions to PTV with concurrent S-1) . At the most recent follow-up in March 2026, the patient remained disease-free.  \nConclusion: This case illustrates that SPMs may arise outside irradiated regions after ACC treatment, excluding radiation-induced carcinogenesis. The ﬁndings emphasize the necessity of comprehensive endoscopic surveillance of the entire  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nesophagus for early detection of secondary primaries in patients treated for esophageal ACC. Furthermore, the favorable thera","cbCaimDzDDxAb3rL","https://ap.wps.com/l/cbCaimDzDDxAb3rL","pdf",2275244,"English","# Background\n# Case presentation\n## First primary: esophageal ACC (2022–2023)\n## Metachronous second primary: cervical esophageal SCC\n# Conclusion","[{\"question\":\"What rare clinical scenario does this case report describe?\",\"answer\":\"It describes metachronous dual primary esophageal cancers: adenoid cystic carcinoma followed by squamous cell carcinoma arising outside the previously irradiated field.\"},{\"question\":\"How was the initial esophageal adenoid cystic carcinoma treated?\",\"answer\":\"The patient underwent surgical resection and then received adjuvant radiotherapy to the tumor bed, which was well tolerated.\"},{\"question\":\"What was the outcome after the second primary SCC was detected and treated?\",\"answer\":\"Definitive chemoradiotherapy led to complete remission, and the patient remained disease-free at the latest follow-up in March 2026.\"}]","Successful management of metachronous dual primary esophageal carcinomas: first report of consecutive adenoid cystic carcinoma and squamous cell carcinoma with exceptional treatment outcome - a case report | PDF",1790088734,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0610300b2b8840fbcdd159dea012f8a5.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28c155cbd87acf2df056669bd73be692.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dac07e0c90cb30a6e04fec39f193b577.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cf1e06fb944742f7d54ead8677c955a.webp",980,1385]